This role involves leading and driving strategy for analytical method development and phase-appropriate method validation/transfer activities for small molecule NCEs, from early development through late-stage/commercial readiness. The position owns the analytical strategy for drug substance programs at CDMOs, directing method development, validation, and troubleshooting to enable characterization, release, and stability testing of clinical candidates. The role also includes leading the evaluation and introduction of modern analytical technologies, setting direction for new techniques, and providing senior-level review and approval of method transfer/validation protocols, data sets, and reports. Accountability for QC testing oversight across analytical testing labs and DS manufacturing sites, including vendor performance and quality of deliverables, is also a key aspect. The Associate Director will review and approve method qualification protocols and reports at external laboratories, serve as the final scientific authority on method suitability, and direct the review and QC of raw data from third parties supporting batch release and stability. This includes leading data trending efforts, proactively flagging risks, and driving issue resolution. The role requires managing a portfolio of concurrent projects, prioritizing resources and timelines, and serving as a cross-functional leader partnering with CMC, Quality Assurance, and Regulatory Affairs to shape regulatory and development strategy, representing Analytical Development in various forums.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Senior
Education Level
Ph.D. or professional degree